Miguel-Angel Perales

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Miguel-Angel Perales
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Jul 30, 2024, 07:06 | Insight
Aaron Goodman: An informative paper about CD19 CART timing of complications
Aaron Goodman shared on X about a recent paper by Nausheen Ahmed et al. titled…
Jul 25, 2024, 20:13 | Insight
Optimizing the Post-CAR T Monitoring Period
Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director at Division of HMCT/University…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 14, 2024, 01:25 | Insight
Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!
Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Apr 26, 2024, 20:41 | Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
All: 8 Posts: 1 - 100
Special Coverage